Shaun Bagai, CEO of RenovoRx, joined us to discuss an innovative approach delivering chemo directly to pancreatic tumors. By targeting the cancer more precisely, this treatment may reduce side effects and improve quality of life. We explored how this approach could transform treatment for those with locally advanced pancreatic cancer, the progress being made in clinical trials, and the hope it brings to patients and families.
RenovoRx Announces Peer-Reviewed Publication Highlighting the TAMP™ Platform’s Potential to Improve Chemotherapeutic Delivery for Locally Advanced Pancreatic Cancer
October 1, 2026
RenovoRx today announced the publication of a peer-reviewed case series in Case Reports in Oncology from researchers at Hackensack Meridian Health’s Jersey Shore University Medical Center.